Johnson & Johnson to Participate in the Cowen 42^nd Annual Health Care Virtual Conference

New Brunswick, NJ (February 7^th, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 42^nd Annual Health Care Virtual Conference on Monday, March 7^th. Mathai Mammen, Executive Vice President, Pharmaceuticals R&D will represent the Company in a session scheduled at 9:10 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.